Skip to main content

Table 3 Ethics committee names and approval registration number

From: Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial

Number

Ethics committees’ name

Approval registration number

01

Medical Ethics Committee of Chinese People’s Liberation Army General Hospital

S2016–061-01

02

Medical Ethics Committee of First Affiliated Hospital of Chinese People’s Liberation Army General Hospital

NO

03

Ethics Committee of Chinese People’s Liberation Army General Hospital of Rocket Forces

KY2016035

04

Medical Ethics Committee of Navy General Hospital of Chinese People’s Liberation Army

NO

05

Medical Ethics Committee of Beijing Shijitan Hospital

(2017) R&D Research No. (2)

06

Ethics Committee of Tianjin First Center Hospital

2017N001KY

07

Medical Ethics Committee of The Fourth Affiliated Hospital of China Medical University

2017–001

  1. Every hospital had China Food and Drug Administration (CFDA)-approved qualification for drug clinical trials, and all investigators had a Good Clinical Practice (GCP) certificate